TAG:
test for prostate cancer
Health Insurers Want More Data On Clinical Utility of Molecular, Genetic Tests
CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acc…
CURRENT ISSUE
Volume XXVIII, No. 1 – January 19, 2021
THE DARK REPORT HAS DiSCOVERED that 3 major health systems with 372 hospitals have switched to a different CLIA accreditation organization over the past 18 months. All the details are examined here, including reasons why a health system might make such a switch. Also in this issue is an exclusive newsmaker interview with the CEO of a new company that is challenging the 70-year-standard Coulter Principle technology in hematology.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
